Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             145 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 EDITORIAL BOARD
29 S3 p.
artikel
2 O2- CHARACTERIZATION OF STEATOTIC LIVER DISEASE AND THE ROLE OF GENETIC BACKGROUND IN LATIN AMERICA PIGA, LUIS ANTONIO DÍAZ

29 S3 p.
artikel
3 O-12 DECIPHERING WILSON'S DISEASE IN COSTA RICA: AN INNOVATIVE GENETIC APPROACH Alvarado, Danny

29 S3 p.
artikel
4 OP-5 ACUTE-ON-CHRONIC LIVER FAILURE (ACLF) CRITERIA IN ALCOHOL-ASSOCIATED HEPATITIS: IMPLICATIONS FOR LIVER TRANSPLANTATION PIGA, LUIS ANTONIO DÍAZ

29 S3 p.
artikel
5 OP-9 Assessing the Burden and Budget Impacts of HCV Elimination Strategies in Uruguay Using Decision-Analytic Modeling Rial, Victoria Mainardi

29 S3 p.
artikel
6 OP-3 ASSESSING TREATMENT ELIGIBILITY EXPANSION UNDER THE 2024 WHO GUIDELINES FOR CHRONIC HEPATITIS B Mendizabal, Manuel

29 S3 p.
artikel
7 OP-13 CHOLANGIOCARCINOMA IN LATIN AMERICA: A MULTICENTER OBSERVATIONAL STUDY ALERTS ON ETHNICAL DISPARITIES IN TUMOR PRESENTATION AND OUTCOME Da Fonseca, Leonardo G

29 S3 p.
artikel
8 OP- 11 Detection Strategy for Patients with Viral Hepatitis Using Laboratory Records of Blood Samples for HBsAg and HCV Antibodies: PANRELINK Cairo, Fernando

29 S3 p.
artikel
9 OP- 14 ENHANCED MUSCLE MASS MITIGATES MASLD IN MYOSTATIN KNOCKOUT MICE WITHOUT IMPACTING EXERCISE PERFORMANCE Garcia, Daniel Cabrera

29 S3 p.
artikel
10 OP- 4 EPIDEMIOLOGY OF PRIMARY BILIARY CHOLANGITIS IN LATIN AMERICA: PRELIMINARY RESULTS FROM ALLATIN COHORT Cançado, Guilherme Grossi Lopes

29 S3 p.
artikel
11 OP-6 EVALUATION OF THE HEPATOPROTECTIVE ACTIVITY OF Flourensia cernua AND ITS IMPACT ON THE AEROBIC INTESTINAL MICROBIOTA IN A VALPROIC ACID-INDUCED DAMAGE MODEL IN WISTAR RATS González, Liliana Torres

29 S3 p.
artikel
12 OP-16 FREQUENCY OF ATP7B GENE MUTATIONS IN A BRAZILIAN COHORT OF PATIENTS WITH WILSON'S DISEASE Chindamo, Maria Chiara

29 S3 p.
artikel
13 OP-7 Further exploration of differences between lean and non-lean metabolic dysfunction-associated steatotic liver disease (MASLD) in Latino subjects: PNPLA3 frequency and lipidomic profiles VALVERDE, MARIA AYALA

29 S3 p.
artikel
14 OP-1 LONG-TERM EFFICACY AND SAFETY OF OPEN-LABEL SELADELPAR TREATMENT IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS: INTERIM 2-YEAR RESULTS FROM THE ASSURE STUDY Trivedi, Palak J.

29 S3 p.
artikel
15 OP- 10 - NON-STEROIDAL ANTI-INFLAMMATORY DRUGS: A COMPARATIVE ANALYSIS BETWEEN THE SPANISH AND LATINDILI NETWORKS BESSONE, FERNANDO

29 S3 p.
artikel
16 OP- 15 OUTCOME OF PREGNANCIES IN A SERIES OF WILSON DISEASE PATIENTS Deguti, Marta Mitiko

29 S3 p.
artikel
17 OP-8 SECOND LINE THERAPY IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND INADECUATE RESPONSE: ARE WE CHOOSING THE RIGHT TARGET POPULATION FOR CLINICALS TRIALS? Viña, Daniela De La

29 S3 p.
artikel
18 OP-2 WILSON DISEASE (WD) DIAGNOSIS WITH NEXT-GENERATION SEQUENCING (NGS) IN CLINICAL PRACTICE: A PILOT STUDY Deguti, Marta Mitiko

29 S3 p.
artikel
19 O3- RECOMPENSATION IN PATIENTS WITH CIRRHOSIS PRIOR TO FIRST LINE SYSTEMIC THERAPY IS ASSOCIATED WITH SIMILAR SURVIVAL OUTCOMES COMPARED TO COMPENSATED CIRRHOSIS PIÑERO, FEDERICO

29 S3 p.
artikel
20 O-1 SIMULTANEOUS LIVER-KIDNEY TRANSPLANTATION OUTCOMES IN LATIN AMERICA Morales, Jorge Carlos Martinez

29 S3 p.
artikel
21 P-32 ACCESSIBILITY TO SEQUENTIAL SYSTEMIC TREATMENT AFTER TACE: IMPACT ON SURVIVAL IN A LATIN AMERICAN PROSPECTIVE COHORT PIÑERO, FEDERICO

29 S3 p.
artikel
22 P-31 ACUTE LIVER FAILURE DUE TO WILSON'S DISEASE IN COSTA RICA: A LOOK AT GENETICS Corrales, Jorge Andres Herrera

29 S3 p.
artikel
23 P-89 ADHERENCE TO IMMUNOSUPPRESSIVE THERAPY IN LIVER TRANSPLANT PATIENTS: FACTORS ASSOCIATED TO COMPLIANCE AND IMPACT ON QUALITY OF LIFE Roa, Carol

29 S3 p.
artikel
24 P-112 ADVANCED FIBROSIS IN PATIENTS WITH LIVER STEATOSIS MEASURED BY FIBROSCAN AND ITS ASSOCIATED FACTORS Cattaneo, Máximo

29 S3 p.
artikel
25 P-5 A LARGE REGISTER OF LIVER STIFFNESS AND STEATOSIS BY TRANSIENT ELASTOGRAPHY IN METABOLIC ASSOCIATED STEATOTIC LIVER DISEASE – THE FIRST STEP FOR AN ADEQUATE PATIENT ALLOCATION Cardoso, Ana Carolina

29 S3 p.
artikel
26 P-34 ALBUMIN-BILIRUBIN GRADE ANALYSIS OF OVERALL SURVIVAL WITH ATEZOLIZUMAB PLUS BEVACIZUMAB IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA Borges, Cristina Cheinquer Coelho

29 S3 p.
artikel
27 P-70 ALCOHOL CONSUMPTION RECURRENCE IN LIVER TRANSPLANT PATIENTS WITH ALCOHOLIC CIRRHOSIS: HEALTH AND SOCIAL IMPACT Cairo, Fernando

29 S3 p.
artikel
28 P-109 ALKALINE PHOSPHATASE AND CIRRHOSIS AT DIAGNOSIS ARE ASSOCIATED WITH DEEP RESPONSE TO URSODEOXYCHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS Cançado, Guilherme Grossi Lopes

29 S3 p.
artikel
29 P-17 AMIKACIN USE AND RISK OF NEPHROTOXICITY IN PATIENTS WITH LIVER CIRRHOSIS HOSPITALIZED FOR SEPSIS Saez, Alonso

29 S3 p.
artikel
30 P-54 ANALYSIS OF FACTORS ASSOCIATED WITH STEATOTIC LIVER DISEASE IN SUBJECTS WITH INFLAMMATORY BOWEL DISEASE: A RETROSPECTIVE CROSS-SECTIONAL STUDY IN THE CHILEAN POPULATION Arriaza, Diego Motto

29 S3 p.
artikel
31 P-45 ANALYSIS OF SURVIVAL RATE AND FACTORS ASSOCIATED WITH LIVER RETRANSPLANTATION: 18-YEAR EXPERIENCE IN BOGOTÁ - COLOMBIA Dueñas, Andres

29 S3 p.
artikel
32 P-103 AN ELEVATED BASELINE LEVEL OF ALKALINE PHOSPHATASE, ALANINE AMINOTRANSFERASE, AND ASPARTATE AMINOTRANSFERASE PREDICT A LACK OF BIOCHEMICAL RESPONSE TO UDCA THERAPY AMONG HISPANIC PATIENTS LIVING WITH PRIMARY BILIARY CHOLANGITIS RENTERIA, LUIS ALEJANDRO ROSALES

29 S3 p.
artikel
33 P-18 ANTI-HBC POSITIVITY IS AN INDEPENDENT PREDICTIVE FACTOR FOR HCC DEVELOPMENT AND SHOULD BE INCORPORATED TO THE HCC RISK SCORE PREDICTION MODEL IN ADVANCED FIBROSIS Gomes, Marcus Vinicius de Acevedo Garcia

29 S3 p.
artikel
34 P-42 ASSESSING THE TRAINING NEEDS OF PERUVIAN HEALTHCARE PROFESSIONALS VILLALOBOS, CESAR CASTRO

29 S3 p.
artikel
35 P-124 ASSOCIATED FACTORS WITH CLINICAL COURSE OF VASCULAR LIVER DISEASE IN A PUBLIC HOSPITAL IN PERU VILLALOBOS, CESAR CASTRO

29 S3 p.
artikel
36 P-40 ASSOCIATION BETWEEN LIVER STIFFNESS MEASUREMENTS USING MR ELASTOGRAPHY AND PORTOSYSTEMIC SHUNTS IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE Pereira, Rodrigo Pereira Luz

29 S3 p.
artikel
37 P-19 ASSOCIATION OF TM6SF2 GENE POLYMORPHISMS WITH CARDIOVASCULAR RISK IN PATIENTS WITH METABOLIC DYSFUNCTION–ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) IN A HISPANIC ADULT POPULATION CUERVO, LUISA FERNANDA SANTOS

29 S3 p.
artikel
38 P-71 BARIATRIC SURGERY AND THE IMPACT ON THE LIVER. COHORT STUDY OF ONE CENTER IN ARGENTINA Cortese, Maria Mercedes

29 S3 p.
artikel
39 P-60 CAN A DOPPLER ULTRASOUND PREDICT VARICEAL HEMORRHAGE AND CORRELATE WITH THE MELD 3.0 SCORE IN LIVER CIRRHOSIS PATIENTS? A RETROSPECTIVE STUDY Casanova, Lucia Amairani Robles

29 S3 p.
artikel
40 P-92 CAN HONEY AND APICULTURAL DERIVATIVES HELP IN FATTY LIVER DISEASE? Urquiza, Liena Martina Bravo

29 S3 p.
artikel
41 P-110 CHANGES IN THE CLINICAL PRESENTATION OF PRIMARY BILIARY CHOLANGITIS (PBC) OVER THE YEARS IN A UNIVERSITY CENTER IN ARGENTINA Bori, Matías Sebastián

29 S3 p.
artikel
42 P-63 CHARACTERISTICS AND CLINICAL OUTCOMES IN CIRRHOTIC PATIENTS TREATED IN ICU BETWEEN 2018-2023 Kozhakin, Daniel Rojas

29 S3 p.
artikel
43 P-79 CHARACTERISTICS AND OUTCOMES OF TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) RECIPIENTS IN A TERTIARY HOSPITAL. LIMA - PERU (JANUARY 2019 - MARCH 2024) Bolaños, Ricardo Alejandro Rocha

29 S3 p.
artikel
44 P-28 CHARACTERIZATION OF CHRONIC LIVER DISEASE, CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA PROGRESSION IN A COLOMBIAN HEALTH MAINTENANCE ORGANIZATION: A TEN-YEAR RETROSPECTIVE STUDY Sierra, Joshua Kock

29 S3 p.
artikel
45 P-99 CHARACTERIZATION OF PATIENTS WITH LIVER CIRRHOSIS, ITS COMPLICATIONS AND SURVIVAL. Suárez, Dayron Páez

29 S3 p.
artikel
46 P-111 CHARACTERIZATION OF PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS, IN TWO REFERENCE CENTERS, FROM 2011 TO 2023 Bogado, Lorena Sofía Martínez

29 S3 p.
artikel
47 P-52 CHARACTERIZATION OF SERUM METABOLOMIC PROFILE BY NMR IN PATIENTS WITH VARIOUS DEGREES OF HEPATIC ENCEPHALOPATHY. Pérez, Paula Cordero

29 S3 p.
artikel
48 P-50 CLINICAL AND DEMOGRAPHIC CHARACTERISTICS OF PATIENTS WITH ACUTE HEPATITIS B VIRUS IN A PUBLICAL HOSPITAL IN CHILE FROM 2015 TO 2022. Barahona, Herman Aguirre

29 S3 p.
artikel
49 P-35 CLINICAL AND EPIDEMIOLOGICAL DIFFERENCES BETWEEN PATIENTS MONOINFECTED WITH HEPATITIS B AND COINFECTED WITH HEPATITIS DELTA IN A HYPERENDEMIC REGION OF HEPATITIS B Junior, Walter Silva Junior

29 S3 p.
artikel
50 P-61 CLINICAL APPLICATION OF NAFLD FIBROSIS SCORE AND HEPAMET FIBROSIS SCORE IN CORONARY ARTERY DISEASE AND MASLD: A CROSS-SECTIONAL STUDY IN WESTERN MEXICAN POPULATION Chávez, José Antonio Velarde

29 S3 p.
artikel
51 P- 114 CLINICAL CHARACTERIZATION OF CIRRHOTIC PATIENTS HOSPITALIZED AT THE CARDIOINFANTIL FOUNDATION: A NEW PERSPECTIVE Kozhakin, Daniel Rojas

29 S3 p.
artikel
52 P-123 CLINICAL COURSE OF PATIENTS WITH CHOLESTATIC LIVER DISEASES IN A LIVER TRANSPLANT CENTER Rodríguez, Harlim Rodríguez

29 S3 p.
artikel
53 P-107 CLINICAL SPECTRUM OF METABOLIC DYSFUNCTION–ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) IN PATIENTS WITH ALTERED ANKLE-BRACHIAL INDEX (ABI) AND CARDIOVASCULAR (CV) RISK FACTORS. Calderón, Diana Karen Tapia

29 S3 p.
artikel
54 P-33 COMBINATION OF FIB-4 SCORE AND D-DIMER TO PREDICT OUTCOME IN HOSPITALIZED COVID-19 PATIENTS Manhães, Fernanda Pozzobon

29 S3 p.
artikel
55 P-90 COMPARISON BETWEEN MILAN CRITERIA, FRENCH ALPHA-FETOPROTEIN MODEL, AND METROTICKET 2.0 FOR LIVER TRANSPLANTATION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA. Auba, Victor Nicolas Henriquez

29 S3 p.
artikel
56 P-48 COMPARISON OF THE ALBI MODEL (ALBUMIN/BILIRUBIN INDEX) WITH ESTABLISHED SCALES AS PREDICTOR OF RESPONSE TO STEROID TREATMENT IN PATIENTS WITH SEVERE ALCOHOLIC HEPATITIS NAVA, CLAUDIA LETICIA DORANTES

29 S3 p.
artikel
57 P-117 CONTINUOUS INTRAVENOUS TACROLIMUS FOR LIVER TRANSPLANT RECIPIENTS: IMPLEMENTATION STRATEGY AND CLINICAL OUTCOMES LONDOÑO, CAMILO ANDRES TORRES

29 S3 p.
artikel
58 P-6 CORRELATION BETWEEN CONNECTIVE TISSUE GROWTH FACTOR (CTGF) AND FIBROSIS DEGREE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (PBC) Sánchez, Cristian Yamín Sánchez

29 S3 p.
artikel
59 P-100 CORRELATION OF TWO TRANSIENT ELASTOGRAPHY EQUIPMENT FOR ESTIMATION OF LIVER STEATOSIS AND LIVER FIBROSIS Mendoza, Raul Alfonso Gomez

29 S3 p.
artikel
60 P-78 DECOMPENSATED CIRRHOSIS IN A LARGE MULTINATIONAL COHORT IN LATIN AMERICA: MORTALITY IS TOO HIGH IN THE REGION REGARDLESS OF ETIOLOGY AND COUNTRY Reis, Mario Alvares-Da-Silva

29 S3 p.
artikel
61 P-47 DEGREES OF LIVER STIFFNESS AND STEATOSIS AS PREDICTORS OF PREECLAMPSIA COMPLICATIONS Hernandez, Jose Luis Perez

29 S3 p.
artikel
62 P-93 DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION IN A PUBLIC HOSPITAL IN CHILE BETWEEN YEARS 2015 AND 2022 Barahona, Herman Aguirre

29 S3 p.
artikel
63 P-24 DESCRIPTION OF SERUM MICRORNAS EXPRESSION AMONG INDIVIDUALS WITH VIRAL HEPATITIS AND LONG COVID Lima, Lucas da Silva

29 S3 p.
artikel
64 P-14 DETECTION OF CIRRHOSIS DUE TO ALPHA-1 ANTITRYPSIN DEFICIENCY IN ADULTS: PHENOTYPE STUDY IN COSTA RICA Carit, Fernanda Vásquez

29 S3 p.
artikel
65 P- 1 DEVELOPMENT OF LENTIVIRAL VECTORS FOR INHIBITION OF HEPATITIS B VIRUS, VIA SMALL INTERFERING RNA Paula, Giovana Angelice

29 S3 p.
artikel
66 P-106 DIAGNOSTIC ACCURACY OF SHEAR-WAVE ELASTOGRAPHY IN METABOLIC DYSFUNCTION–ASSOCIATED STEATOTIC LIVER DISEASE, A SINGLE CENTER REPORT ACERO, LUIS CARLOS ARAYA

29 S3 p.
artikel
67 P-29 DIFFERENCES IN THE PROGRESSION OF BODY COMPOSITION AND LIVER DAMAGE IN A MURINE MODEL OF METABOLIC SYNDROME: A SEX PERSPECTIVE Manjarrés, Laura

29 S3 p.
artikel
68 P-64 DOWNSTAGING STRATEGY FOR LIVER TRANSPLANTATION IN HEPATOCELLULAR CARCINOMA. A COHORT STUDY IN A COLOMBIAN HOSPITAL Marin-Zuluaga, Juan Ignacio

29 S3 p.
artikel
69 P-49 EFFECT OF STATINS IN REVERSING CELL GROWTH DYSREGULATION IN THE EARLY STAGES OF HEPATOCARCINOGENESIS Coli, Lucia

29 S3 p.
artikel
70 P-69 EFFECTS OF POPULATIONAL-RELEVANT DOSES OF CARBOXYMETHYLCELLULOSE AND POLYSORBATE 80 EMULSIFIERS ON MASLD-ASSOCIATED HEPATOCARCINOGENESIS PRATA, GABRIEL BACIL

29 S3 p.
artikel
71 P-37 ENHANCED DIAGNOSTIC ACCURACY OF FIB-4 WITH M30 FOR IDENTIFYING AT-RISK PATIENTS WITH STEATOTIC LIVER DISEASE Avilés, Camila

29 S3 p.
artikel
72 P-7 EPIDEMIOLOGY OF AUTOIMMUNE HEPATITIS IN LATIN AMERICA: PRELIMINARY RESULTS FROM ALLATIN COHORT Cançado, Guilherme Grossi Lopes

29 S3 p.
artikel
73 P-26 EPIGENETIC MARKS IN PATIENTS WITH SUSTAINED VIRAL RESPONSE TO HCV AND RESIDUAL LIVER FIBROSIS ARE RESTORED BY PROLONGED-RELEASE PIRFENIDONE Reyes, Eira Cerda

29 S3 p.
artikel
74 P-38 EVALUATION OF THE GENETIC AND VIROLOGICAL PROFILE OF PREGNANT WOMEN INFECTED WITH HEPATITIS B AND C VIRUSES IN A REFERENCE CENTER IN RIO DE JANEIRO, BETWEEN 2016 AND 2022 Pedro, Kaio Ferreira Callebe

29 S3 p.
artikel
75 P-113 EVALUATION OF THE MELNA AGIB SCALE TO PREDICT MORTALITY IN PATIENTS WITH CIRRHOSIS AND VARICEAL HEMORRHAGE Castillo, Miguel Yael Carmona

29 S3 p.
artikel
76 P-13 EVALUATION OF UNDIAGNOSED ALCOHOLIC LIVER DISEASE IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE USING THE ANI SCORE Mateu, Carlos Alventosa

29 S3 p.
artikel
77 P-56 EXPERIENCE WITH DEXMEDETOMIDINE IN THE MANAGEMENT OF ALCOHOL WITHDRAWAL SYNDROME FOR PATIENTS WITH CIRRHOSIS Gonzalez, Liliana Ivonne Gallardo

29 S3 p.
artikel
78 P-3 FACTORS ASSOCIATED WITH AN IMPROVEMENT IN SEQUENTIAL LIVER STIFFNESS MEASURES BY TRANSIENT ELASTOGRAPHY IN MASLD PATIENTS WITH PREDIABETES AND TYPE 2 DIABETES. Santos, Lorrane Viana

29 S3 p.
artikel
79 P-125 FACTORS ASSOCIATED WITH THE DEVELOPMENT OF POST-BANDING ULCER BLEEDING IN PATIENTS WITH CIRRHOSIS. Carrión, Sandra Teutli

29 S3 p.
artikel
80 P-55 FIRST EVALUATION ALBI SCORE COULD BE A TOOL FOR RISK STRATIFICATION OF HCC DEVELOPMENT IN PATIENTS WITH CHRONIC HEPATITIS C AND CIRRHOSIS Maccali, Claudia

29 S3 p.
artikel
81 P-67 FREQUENCY OF MASLD IN INFLAMMATORY BOWEL DISEASE CONTRERAS, JAIME ISRAEL CERVANTES

29 S3 p.
artikel
82 P- 15 GENETIC AND CLINICAL CHARACTERISTICS IN LEAN MASLD PATIENTS WITH AND WITHOUT CIRRHOSIS IN LATINOAMERICAN POPULATION Espinoza, Karina Sato

29 S3 p.
artikel
83 P-74 GLYCOSYLATED HEMOGLOBIN LEVELS AS A PREDICTOR OF HEPATIC FIBROSIS DUE TO MASLD Hernández, Stefanny Cornejo

29 S3 p.
artikel
84 P-84 HAVE CFTR MODULATORS CHANGED THE NEED FOR LIVER TRANSPLANTATION AMONG PATIENTS WITH CYSTIC FIBROSIS? AN ANALYSIS OF THE UNOS DATABASE MENDIZABAL, MANUEL

29 S3 p.
artikel
85 P-122 HELICOBACTER PYLORI AS A RISK FACTOR FOR ENCEPHALOPATHY IN PATIENTS WITH CIRRHOSIS Partida, Ana Emilia Jiménez

29 S3 p.
artikel
86 P-72 HEPATITIS B AND C VIRUS PREVALENCE USING RAPID TEST IN A CHILEAN COHORT Valenzuela, Javier Eduardo Pérez

29 S3 p.
artikel
87 P-20 HIGH PREVALENCE OF CHRONIC HEPATITIS B IN ACHE COMMUNITIES IN THE DEPARTMENT OF CANINDEYU-PARAGUAY Duba, Sebastián Díaz

29 S3 p.
artikel
88 P-115 HLA-DRB1*03 /HLA-DRB1*12 ARE ASSOCIATED WITH AUTOIMMUNE HEPATITIS IN A HISPANIC ADULT POPULATION Puerta, Adriana Varon

29 S3 p.
artikel
89 P-4 HYPOTHERMIC OXYGENATED PERFUSION USING AN ECMO DEVICE IN LIVER TRANSPLANTATION: AN ANALYSIS OF THE FIRST 100 CASES AT A CHILEAN PUBLIC HOSPITAL VENEZIAN, FRANCISCA MAGDALENA MARTÍNEZ

29 S3 p.
artikel
90 P-53 IMMUNE-MEDIATED ADVERSE EVENTS FOLLOWING ATEZOLIZUMAB PLUS BEVACIZUMAB IS ASSOCIATED WITH DECREASED SURVIVAL IN PATIENTS WITH CIRRHOSIS PIÑERO, FEDERICO

29 S3 p.
artikel
91 P-46 IMMUNOSUPPRESSION IN POST LIVER TRANSPLANTATION: REVIEW OF THE EXPERIENCE IN A CHILEAN UNIVERSITY HOSPITAL Ruiz, Richard Esteban Martinez

29 S3 p.
artikel
92 P-82 IMPACT OF HEPATITIS C VIRUS ERADICATION WITH DIRECT ANTIVIRAL DRUGS ON GLYCEMIC CONTROL AFTER LIVER TRANSPLANTATION de Oliveira, Alicia Araújo

29 S3 p.
artikel
93 P-85 IMPACT OF TECHNICAL NOTE No 32/2021 ON THE RATE OF LIVER TRANSPLANTS FOR REFRACTORY ASCITIS IN A TERTIARY HOSPITAL Fontanini, Guilherme Massote

29 S3 p.
artikel
94 P-25 IMPEDANCE CARDIOGRAPHY AND SPLEEN STIFFNESS MEASUREMENT TO ASSESS THERAPEUTIC RESPONSE IN CIRRHOTIC PATIENTS TREATED WITH NON-CARDIOSELECTIVE BETA-BLOCKERS Barceló, Martín Elizondo

29 S3 p.
artikel
95 P-66 INCIDENCE AND FACTORS ASSOCIATED WITH ONE-YEAR POST-LIVER TRANSPLANT REJECTION AND MORTALITY, A COHORT STUDY Aguilera, Vicente Arancibia

29 S3 p.
artikel
96 P-75 INFLUENCE OF THE ARTERIAL HEPATIC FLOW IN ELASTOGRAPHY (2D SHEARWAVE) LIVER VALUES Arufe, Diego

29 S3 p.
artikel
97 P-98 LACTATE/ALBUMIN RATIO AS A MARKER OF MORTALITY IN PATIENTS HOSPITALIZED WITH ACUTE ON CHRONIC LIVER FAILURE IN A MEXICAN HOSPITAL: CLINICAL ANALYSIS AND PERSPECTIVES Arroy, Gabriela Bretón

29 S3 p.
artikel
98 P-81 LIVER TRANSPLANTATION FOR PRIMARY BILIARY CHOLANGITIS (PBC): 25-YEAR EXPERIENCE. Oliveira, Manuella Sobral Andrade

29 S3 p.
artikel
99 P-68 LIVGUARD, A DEEP NEURAL NETWORK FOR CIRRHOSIS DETECTION IN LIVER ULTRASOUND (USD) IMAGES ARUFE, DIEGO

29 S3 p.
artikel
100 P-96 LONG-TERM PIOGLITAZONE TREATMENT AND LIVER STIFFNESS IN MASLD PATIENTS: INSIGHTS FROM A MULTICENTRIC STUDY Pessoa, Mario Guimarães

29 S3 p.
artikel
101 P-44 LONG-TERM SURVIVAL IN PATIENTS WITH LIVER TRANSPLANTATION SUAREZ, MARCIA SAMADA

29 S3 p.
artikel
102 P-108 MAFLD-S SCORE: A CONVENIENT CLINICAL TOOL FOR PREDICTING MASLD IN PRIMARY CARE SETTINGS DÍAZ, JUAN ADRIÁN TORRES

29 S3 p.
artikel
103 P-76 MANIFESTATIONS OF PORTAL HYPERTENSION IN PATIENTS WITH COMMON VARIABLE IMMUNODEFICIENCY: PRELIMINARY DATA GUIDO, VERONICA

29 S3 p.
artikel
104 P-118 METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: INDICATION FOR LIVER TRANSPLANTATION AND OCCURRENCE IN THE POSTOPERATIVE PERIOD Caprini, Felipe Ramos

29 S3 p.
artikel
105 P-12 METHYL GROUP DONOR SUPPLEMENTATION IN A MetALD MODEL: REGULATION OF GUT MICROBIOTA AND METABOLIC PARAMETERS Canul, Carolina Díaz

29 S3 p.
artikel
106 P-94 MICROBIOLOGY OF INFECTIONS IN PATIENTS WITH LIVER CIRRHOSIS HOSPITALIZED AT THE CLINICAL HOSPITAL OF THE UNIVERSITY OF CHILE Alcayaga, Allyson Cid

29 S3 p.
artikel
107 P-41 MICRORNAs FROM EVs AS POTENTIAL LIVER FIBROSIS NON-INVASIVE BIOMARKERS IN CHRONIC HEPATITIS C Cairoli, Victoria

29 S3 p.
artikel
108 P-65 NEOPORTA WITH OR WITHOUT TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT AS A VIABLE TREATMENT OF CHRONIC PORTAL VEIN THROMBOSIS IN PATIENTS WITH DECOMPENSATED CIRRHOSIS Olmos, Issac Octavio Vargas

29 S3 p.
artikel
109 P-73 NORADRENALINE IN THE TREATMENT OF HEPATORENAL SYNDROME TYPE AKI: RESULTS IN NON-ICU HOSPITAL SETTING Damián, Zuly Plácido

29 S3 p.
artikel
110 P-91 NORMALIZATION OF ALKALINE PHOSPHATASE COMPARED TO CONVENTIONAL RESPONSE CRITERIA LEADS TO LOWER LIVER RELATED EVENTS AND MORTALITY IN PATIENTS LIVING WITH PRIMARY BILIARY CHOLANGITIS, TREATED WITH UDCA: A RETROSPECTIVE, PROPENSITY SCORED-MATCHED, COHORT STUDY RENTERIA, LUIS ALEJANDRO ROSALES

29 S3 p.
artikel
111 P-30 NURSING EXPERIENCE IN THE ONLY ADULT-TO-ADULT LIVING DONOR LIVER TRANSPLANT PROGRAM IN COLOMBIA CAMARGO, ANA MARÍA MARTINEZ

29 S3 p.
artikel
112 P-27 OBESITY AND LIVER STEATOSIS IN ADOLESCENTS AND YOUNG ADULTS - RELATED FACTORS AND THE IMPACT OF LIFESTYLE Basilio, Fabiana Martins

29 S3 p.
artikel
113 P-102 PERFORMANCE OF NONINVASIVE METHODS TO GRADUATE FIBROSIS AND INFLAMMATION IN A GROUP OF PATIENTS WITH AUTOIMMUNE HEPATITIS ROTMAN, VIVIAN

29 S3 p.
artikel
114 P-101 PHYSICAL AND NUTRITIONAL INTERVENTION EFFECTIVELY REDUCED FRAILTY IN PATIENTS WITH CIRRHOSIS LISTED FOR LIVER TRANSPLANTATION. RANDOMIZED, CONTROLLED TRIAL. GAJARDO, CARLOS BENÍTEZ

29 S3 p.
artikel
115 P-58 PILOT STUDY OF HEPATITIS E VIRUS SEROPREVALENCE IN HEPATITIS B AND DELTA CARRIERS IN THE WESTERN AMAZON Andrade, Caio Lopes Borges

29 S3 p.
artikel
116 P-120 POLYMORPHISMS OF HLA (LOCI DR 4*) IN HISPANICS AS RISK FACTOR FOR DE-NOVO AUTOIMMUNE HEPATITIS AFTER LIVER TRANSPLANTATION Puerta, Adriana Varon

29 S3 p.
artikel
117 P-23 PORTAL VEIN THROMBOSIS IS ASSOCIATED WITH HEPATIC DECOMPENSATIONS WITHOUT LIVER STIFFNESS INCREASE IN HEPATOSPLENIC SCHISTOSOMIASIS Theodoro, Rafael

29 S3 p.
artikel
118 P-119 POST-TRANSPLANT OVERALL AND GRAFT SURVIVAL AFTER LIVER TRANSPLANTATION FOR AUTOIMMUNE HEPATITIS Resende, Ludmila Guedes

29 S3 p.
artikel
119 P-116 PREDICTION OF CIRRHOSIS THROUGH THE VELOCITY TIME INTEGRAL OF PORTAL VEIN TRACE Arufe, Diego

29 S3 p.
artikel
120 P-39 PREVALENCE AND FACTORS ASSOCIATED WITH TREATMENT ADHERENCE IN LIVER TRANSPLANT PATIENTS ATTENDED AT LACARDIO, BOGOTÁ, COLOMBIA Galvis, Oscar Alfredo Beltran

29 S3 p.
artikel
121 P-104 PREVALENCE AND SEVERITY OF MASLD AND ITS ASSOCIATION WITH METABOLIC COMORBIDITIES: INSIGHTS FROM A LINKAGE TO CARE PROGRAM FOR FATTY LIVER DISEASE Roca, Ignacio

29 S3 p.
artikel
122 P-43 PROGNOSTIC MODELS AFTER TRANSARTERIAL CHEMOEMBOLIZATION IN A LATIN AMERICAN PROSPECTIVE COHORT STUDY PIÑERO, FEDERICO

29 S3 p.
artikel
123 P-11 REAL-WORLD DATA WITH PANGENOTYPIC DIRECT-ACTING ANTIVIRALS IN LATINAMERICA: PRELIMINARY RESULTS OF THE SVR10K STUDY da Silva, Mario Alvares

29 S3 p.
artikel
124 P-2 RECAM VS. RUCAM: ADVANCING THE DIAGNOSIS OF IDIOSYNCRATIC DILI WITH A REVISED ELECTRONIC APPROACH. Pillajo, Sara

29 S3 p.
artikel
125 P-80 RECURRENCE OF PRIMARY SCLEROSING CHOLANGITIS AFTER LIVER TRANSPLANTATION: RESULTS FROM THE BRAZILIAN CHOLESTASIS CONSORTIUM Bittencourt, Paulo Lisboa

29 S3 p.
artikel
126 P-83 REDUCTION OF LIVER STIFFNESS AFTER ANTICOPPER THERAPY IN WILSON'S DISEASE Chindamo, Maria Chiara

29 S3 p.
artikel
127 P-105 RISK FACTORS FOR MORTALITY IN PATIENTS WITH DECOMPENSATED CIRRHOSIS DURING HOSPITALIZATION Rivera, Diego Fernando Abendaño

29 S3 p.
artikel
128 P-88 rs641738 MBOAT7 POLYMORPHISM AS A PREDICTOR OF FIBROSIS IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) Rocha, Sofia

29 S3 p.
artikel
129 P-62 SARCOPENIA AND PSOAS MUSCLE DENSITY ARE INDEPENDENT PREDICTORS OF SURVIVAL OF LIVER TRANSPLANT RECIPIENTS GAJRADO, CARLOS BENÍTEZ

29 S3 p.
artikel
130 P-95 SARCOPENIA: RISK FACTOR FOR MORTALITY IN CIRRHOTIC PATIENTS ON WAITING LIST FOR LIVER TRANSPLANTATION IN A REFERENCE CENTER, COLOMBIA Nassif, Gustavo Andres Diaz

29 S3 p.
artikel
131 P-121 SEPTIC SHOCK IN LIVER CIRRHOSIS: A COHORT STUDY OF A UNIVERSITY HOSPITAL IN CHILE Padilla, Carlos

29 S3 p.
artikel
132 P-10 SEROPREVALENCE OF CHRONIC HEPATITIS C INFECTION AND VIROLOGICAL CURE WITH A DAILY ADMINISTRATION SYSTEM OF NS3/4A PROTEASE INHIBITOR AND NS5A INHIBITOR IN IMPRISONED PATIENTS. FLORES, VÍCTOR MANUEL FONG

29 S3 p.
artikel
133 P-86 SHORT TERM RESULTS OF TRANSPLANTED ACLF PATIENTS IN A YOUNG TRANSPLANT PROGRAM IN CHILE Montequin, Matias Sanhueza

29 S3 p.
artikel
134 P-59 SOCIAL DETERMINANTS OF HEALTH AND INEQUITIES IN CHRONIC DISEASES: THE CASE OF LIVER DISEASES Cuervo, Luisa Fernanda Santos

29 S3 p.
artikel
135 P-9 SURVIVAL ANALYSIS OF A BRAZILIAN COHORT OF PATIENTS WITH WILSON DISEASE Chindamo, Maria Chiara

29 S3 p.
artikel
136 P-57 SUSCEPTIBILITY PATTERNS AND EMPIRICAL ANTIBIOTIC GUIDANCE FOR URINARY TRACT INFECTIONS IN PATIENTS WITH CIRRHOSIS Vazquez, Carolina

29 S3 p.
artikel
137 P-36 THE PROGNOSTIC ROLE OF NEUTROPHIL-LYMPHOCYTE RATIO IN PATIENTS WITH ALCOHOLIC HEPATITIS Flores, Moises Coutiño

29 S3 p.
artikel
138 P-97 THE ROLE OF PSYCHOLOGICAL STRESS IN METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE. A PILOT STUDY Franco, Larissa Aleman

29 S3 p.
artikel
139 P-21 THE ROLE SP-INDUCED MAST CELL ACTIVATION IN LIVER FIBROSIS Franco, Larissa Aleman

29 S3 p.
artikel
140 P-87 TRANSCULTURAL ADAPTATION OF THE MEDITERRANEAN DIET TO THE DIETARY HABITS OF EACH GEOGRAPHICAL REGION OF ARGENTINA FOR THE TREATMENT OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) Crosetti, Maria Adela

29 S3 p.
artikel
141 P-51 TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS), EXPERIENCE IN A UNIVERSITY CENTER Alegría, Caterina Chesta

29 S3 p.
artikel
142 P-8 TRENDS IN ALCOHOL-ASSOCIATED CIRRHOSIS IN CHILE: A POPULATION STUDY BETWEEN 2001 TO 2020. Alarcón, Ignacio

29 S3 p.
artikel
143 P-77 TRIPLE THERAPY FOR DIFFICULT-TO-TREAT PRIMARY BILIARY CHOLANGITIS: A SYSTEMATIC REVIEW AND SINGLE-ARM META-ANALYSIS de Abreu, Eliabe Silva

29 S3 p.
artikel
144 P-16 UNLOCKING S-PINDOLOL'S POTENTIAL FOR MASLD: BENEFICIAL EFFECTS ON MUSCLE MASS AND FUNCTION AND LIVER HISTOLOGY IN WESTERN- DIET FED MICE Cabrera, Daniel

29 S3 p.
artikel
145 P-22 URINARY BIOMARKER NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) FOR IDENTIFYING ACUTE KIDNEY INJURY IN PATIENTS WITH SEVERE ALCOHOLIC HEPATITIS AND CIRRHOSIS Sánchez, Cristian Yamín Sánchez

29 S3 p.
artikel
                             145 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland